Simultaneous determination of twelve benzodiazepines in human serum using a new reversed-phase chromatographic column on a 2-microns porous microspherical silica gel.
A high-performance liquid chromatographic method has been developed for the simultaneous analysis of twelve frequently used benzodiazepines (BZPs) (bromazepam, clonazepam, chlordiazepoxide, estazolam, etizolam, flutazoram, haloxazolam, lorazepam, nitrazepam, oxazolam, triazolam and diazepam, internal standard) by using commercially available 2 or 5 microns particle size reversed-phase columns and a microflow cell-equipped ultraviolet detector. The separation was achieved using a C18 reversed-phase column (condition 1: 100 x 4.6 mm I.D., particle size 2 microns, TSK gel Super-ODS: conditon 2: 100 x 4.6 mm I.D., particle size 5 microns, Hypersil ODS-C18). The mobile phase was composed of methanol-5 mM NaH2PO4 (pH 6) (45:55, v/v), and the flow-rate was 0.65 ml/min (condition 1 and 2). The absorbance of the eluent was monitored at 254 nm. Retention times under condition 1 were shorter than those of condition 2. When the twelve benzodiazepines were determined, sensitivity and limits of quantification were about four to ten times better under condition 1 than under condition 2. The rate of recovery and linearity in condition 1 were approximately the same as those in condition 2. These results show that a new ODS filler with a particle size of 2 microns was more sensitive, provided better separation and was more rapid than that with conventional ODS filler.
Tanaka
E
E
Department of Legal Medicine, University of Tsukuba, Ibaraki-ken, Japan.
Terada
M
M
Misawa
S
S
Wakasugi
C
C
D014151:Anti-Anxiety Agents / Q000097:blood*; D001569:Benzodiazepines / Q000097:blood*; D001570:Benzodiazepinones / Q000097:blood; D001960:Bromazepam / Q000097:blood; D002707:Chlordiazepoxide / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D002998:Clonazepam / Q000097:blood; D003975:Diazepam / Q000097:blood; D004949:Estazolam / Q000097:blood; D006801:Humans; D016014:Linear Models; D008140:Lorazepam / Q000097:blood; D008863:Microspheres; D009567:Nitrazepam / Q000097:blood; D015203:Reproducibility of Results; D012822:Silicon Dioxide / Q000737:chemistry*; D013056:Spectrophotometry, Ultraviolet; D014229:Triazolam / Q000097:blood
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001569:Benzodiazepines; D014229:Triazolam; C000425:oxazolam; D004949:Estazolam; C013367:flutazolam; D002998:Clonazepam; D002707:Chlordiazepoxide; D012822:Silicon Dioxide; D009567:Nitrazepam; C018779:haloxazolam; D008140:Lorazepam; D003975:Diazepam; D001960:Bromazepam